Healthcare DIVE February 7, 2024
Rebecca Pifer

The insurer on Wednesday joined its peers in slamming proposed MA payment rates as insufficient given the dogged increase in medical costs.

Dive Brief:

  • Citing elevated medical costs, CVS Health on Wednesday cut its 2024 outlook despite posting better revenue and earnings than Wall Street had expected in the fourth quarter.
  • The massive healthcare conglomerate now expects to bring in at least $8.30 in adjusted earnings per share this year, compared to prior guidance of $8.50.
  • CVS is the latest insurer to post 2024 guidance below investors’ expectations, after Humana released a disappointing earnings outlook last month.

Dive Insight:

CVS closed out 2023 strong. The Rhode Island-based company brought in $357.8 billion in revenue last year, up 11%...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare Advantage, Provider
Growth in Medicare Advantage Raises Concerns
CMS proposes $21B payment increase for Medicare Advantage in 2026: 10 notes
A Stronger Medicare Program—Now And Into The Future
Medicare Privatization Is Breaking the Bank
Executive Outlook 2025: While MA ‘Tightens the Screws’ on Nursing Homes, Sector Focuses on Reform, Workforce Solutions, I-SNPs

Share This Article